Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

PCO₂ Gap and Lactate as Predictors of POCD After Cardiac Surgery

23 de septiembre de 2026 actualizado por: Ain Shams University

Intraoperative PCO₂ Gap and Lactate Levels as Early Predictors of Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

This prospective observational study aims to evaluate whether intraoperative venous-to-arterial carbon dioxide partial pressure difference (PCO₂ gap) and arterial lactate levels can serve as early predictors of postoperative cognitive dysfunction (POCD) in elderly patients undergoing elective cardiac surgery with cardiopulmonary bypass. Intraoperative measurements of PCO₂ gap and lactate will be correlated with perioperative cognitive outcomes assessed using the Montreal Cognitive Assessment (MoCA) and postoperative delirium screening using the Confusion Assessment Method for the ICU (CAM-ICU).

Descripción general del estudio

Descripción detallada

This prospective observational cohort study will be conducted at El-Demerdash Hospital, Ain Shams University. Patients aged 65 years and older undergoing elective cardiac surgery with cardiopulmonary bypass will be enrolled. Serial measurements of the PCO₂ gap and arterial lactate will be obtained before induction, during CPB, at the end of CPB, 30 minutes after weaning from CPB, and immediately postoperatively. Cognitive function will be evaluated preoperatively and one month after surgery using the Montreal Cognitive Assessment (MoCA). Postoperative delirium will be assessed daily during ICU stay using CAM-ICU. The study will investigate the predictive value of intraoperative PCO₂ gap and lactate levels for postoperative cognitive dysfunction and determine potential cutoff values associated with cognitive decline.

Tipo de estudio

De observación

Inscripción (Estimado)

185

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

65 años y mayores (Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Elderly patients (65 years or older) undergoing elective cardiac surgery with cardiopulmonary bypass at El-Demerdash Hospital, Ain Shams University, Cairo, Egypt. Eligible participants will undergo routine perioperative management with serial intraoperative PCO₂ gap and arterial lactate measurements and perioperative cognitive assessment according to the study protocol.

Descripción

Inclusion Criteria:

  • Age ≥65 years.
  • Undergoing elective cardiac surgery with cardiopulmonary bypass (e.g., coronary artery bypass grafting or valve surgery).
  • American Society of Anesthesiologists (ASA) Physical Status III.
  • Able to provide written informed consent.

Exclusion Criteria:

  • Refusal or inability to provide written informed consent.
  • Pre-existing neurological disorders (e.g., Alzheimer's disease, Parkinson's disease, or stroke with residual neurological deficits).
  • Severe psychiatric disorders requiring active treatment.
  • History of drug or alcohol abuse.
  • Emergency cardiac surgery.
  • Significant visual or hearing impairment interfering with cognitive testing.
  • Inability to complete preoperative cognitive assessment.
  • Preoperative dementia (MoCA score <20).
  • Significant pulmonary disease (e.g., COPD or lung cancer).
  • Patients meeting the protocol-defined intraoperative or postoperative exclusion criteria.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: PROSPECTIVE

Cohortes e Intervenciones

Grupo / Cohorte
Elderly Patients Undergoing Elective Cardiac Surgery with Cardiopulmonary Bypass

Patients aged 65 years or older undergoing elective cardiac surgery with cardiopulmonary bypass. Participants will undergo serial intraoperative measurements of the venous-to-arterial carbon dioxide partial pressure difference (PCO₂ gap) and arterial lactate levels. Postoperative cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), and postoperative delirium will be screened using the Confusion Assessment Method for the ICU (CAM-ICU).

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Predictive Value of Intraoperative PCO₂ Gap and Arterial Lactate Levels for Postoperative Cognitive Dysfunction (POCD
Periodo de tiempo: Baseline (preoperative) and 1 month postoperatively

To evaluate whether intraoperative venous-to-arterial carbon dioxide partial pressure difference (PCO₂ gap) and arterial lactate levels predict postoperative cognitive dysfunction in elderly patients undergoing elective cardiac surgery with cardiopulmonary bypass. POCD will be assessed by changes in Montreal Cognitive Assessment (MoCA) scores from the preoperative baseline to 1 month postoperatively.

Baseline (preoperative) and 1 month postoperatively

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Early Postoperative Delirium Assessed by the Confusion Assessment Method for the ICU (CAM-ICU)
Periodo de tiempo: Daily during the first 5 postoperative days or until ICU discharge, whichever occurs first

To determine the occurrence of early postoperative delirium using the Confusion Assessment Method for the ICU (CAM-ICU). CAM-ICU is a dichotomous assessment (positive or negative), where a positive result indicates the presence of delirium

Daily during the first 5 postoperative days or until ICU discharge, whichever occurs first
Determination of Cutoff Values for Intraoperative PCO₂ Gap and Arterial Lactate Levels Predictive of POCD
Periodo de tiempo: 1 month postoperative

To identify optimal cutoff values for intraoperative PCO₂ gap and arterial lactate levels associated with postoperative cognitive dysfunction in elderly patients undergoing cardiac surgery with cardiopulmonary bypass.The PCO₂ gap will be measured in mmHg, and arterial lactate concentration will be measured in mmol/L.

1 month postoperative
Correlation of (CAM - ICU) to MoCA for prediction of cognitive impairmentat 5 days post operative
Periodo de tiempo: CAM-ICU: Daily during the first 5 postoperative days; MoCA: baseline preoperatively and 1 month postoperatively

To evaluate the correlation between postoperative delirium assessed by the Confusion Assessment Method for the ICU (CAM-ICU) and postoperative cognitive function assessed by the Montreal Cognitive Assessment (MoCA).CAM-ICU will be recorded as a dichotomous result (positive or negative), with a positive result indicating the presence of delirium. MoCA will be recorded as a total score ranging from 0 to 30, with higher scores indicating better cognitive function

CAM-ICU: Daily during the first 5 postoperative days; MoCA: baseline preoperatively and 1 month postoperatively
Incidence of POCD at 1 month postoperatively, defined by a decline in MoCA scores from baseline in elderly cardiac patient.
Periodo de tiempo: Baseline (preoperative) and 1 month postoperatively

To determine the incidence of postoperative cognitive dysfunction, defined as a decline in MoCA score from the preoperative baseline, one month after cardiac surgery

Baseline (preoperative) and 1 month postoperatively
Duration of Mechanical Ventilation in Relation to Intraoperative PCO₂ Gap and Arterial Lactate Levels
Periodo de tiempo: Measured from the end of surgery until successful extubation (up to 30 days)

To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of mechanical ventilation following cardiac surgery with cardiopulmonary bypass. Duration of mechanical ventilation will be measured in hours from the end of surgery until successful extubation, as documented in the patient's medical and ventilator records.

Measured from the end of surgery until successful extubation (up to 30 days)
Duration of Intensive Care Unit Stay in Relation to Intraoperative PCO₂ Gap and Arterial Lactate Levels
Periodo de tiempo: From ICU admission after surgery until ICU discharge, up to 30 days

To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of intensive care unit (ICU) stay following cardiac surgery with cardiopulmonary bypass. ICU stay will be measured in days from ICU admission after surgery until ICU discharge, as documented in the patient's medical records.

From ICU admission after surgery until ICU discharge, up to 30 days
Duration of Hospital Stay in Relation to Intraoperative PCO₂ Gap and Arterial Lactate Levels
Periodo de tiempo: From the end of surgery until hospital discharge, up to 30 days

To evaluate the association between intraoperative PCO₂ gap and arterial lactate levels and the duration of hospital stay following cardiac surgery with cardiopulmonary bypass. Hospital stay will be measured in days from the end of surgery until hospital discharge, as documented in the patient's medical records.

From the end of surgery until hospital discharge, up to 30 days

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de diciembre de 2026

Finalización primaria (Estimado)

1 de mayo de 2028

Finalización del estudio (Estimado)

1 de agosto de 2028

Fechas de registro del estudio

Enviado por primera vez

29 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

23 de septiembre de 2026

Publicado por primera vez (Actual)

25 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

25 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

23 de septiembre de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir